Anaesthesia for cardioversion

Area of Science:

• Cardiology
• Anesthesiology

Background:

• Electrical cardioversion is a common procedure for treating cardiac arrhythmias.
• It often occurs in non-ideal settings (out-of-hours, remote sites) with potentially inexperienced anesthetists.
• Requires understanding of arrhythmia pathophysiology, defibrillation technology, and electrical safety.

Purpose of the Study:

• To review anesthetic considerations for electrical cardioversion.
• To identify ideal anesthetic agents balancing efficacy, safety, and recovery.
• To highlight the importance of pre-procedure checks and careful agent titration.

Main Methods:

• Review of anesthetic agents used for cardioversion.
• Discussion of physiological requirements for cardioversion anesthesia (analgesia, sedation, minimal cardiovascular compromise, rapid recovery).
• Consideration of patient-specific factors like coagulation, electrolytes, and pregnancy.

Main Results:

• Various anesthetic agents have been used with mixed success.
• Propofol emerges as a potentially ideal agent due to its pharmacokinetic and pharmacodynamic properties.
• Careful titration of any chosen anesthetic agent is critical for optimizing outcomes.

Conclusions:

• Safe anesthetic practice is paramount for successful cardioversion, even in emergencies or in pregnant patients.
• Anesthesiologists must balance the need for sedation and analgesia with minimizing cardiovascular compromise.
• Propofol, when carefully titrated, represents a favorable option for cardioversion anesthesia.